KAKEN PHARMACEUTIAL CO., LTD. Logo

KAKEN PHARMACEUTIAL CO., LTD.

Develops and markets pharmaceuticals for dermatology, orthopedics, and surgery.

4521 | T

Overview

Corporate Details

ISIN(s):
JP3207000005
LEI:
Country:
Japan
Address:
文京区本駒込二丁目28番8号

Description

Kaken Pharmaceutical Co., Ltd. is a research and development-driven company that develops, manufactures, and markets prescription pharmaceuticals, medical equipment, and agrochemicals. The company's primary focus is on pharmaceuticals, with significant expertise in dermatology, orthopedics, and surgery. Its portfolio of main products includes Clenafin for onychomycosis, Artz for osteoarthritis, Fiblast for wound healing, and Ecclock for primary axillary hyperhidrosis. Kaken's research and development efforts are concentrated on specific fields, including the immune system, nervous system, and infectious diseases, to create innovative drugs. The company also has business activities in real estate.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-11-13 01:04
四半期報告書-第98期第2四半期(2017/07/01-2017/09/30)
Japanese 176.1 KB
2017-08-10 02:25
四半期報告書-第98期第1四半期(2017/04/01-2017/06/30)
Japanese 138.9 KB
2017-06-29 07:11
有価証券報告書-第97期(2016/04/01-2017/03/31)
Japanese 748.6 KB
2017-02-10 02:07
四半期報告書-第97期第3四半期(2016/10/01-2016/12/31)
Japanese 154.9 KB
2016-11-11 01:21
四半期報告書-第97期第2四半期(2016/07/01-2016/09/30)
Japanese 184.4 KB
2016-08-10 02:30
四半期報告書-第97期第1四半期(2016/04/01-2016/06/30)
Japanese 165.6 KB
2016-06-29 04:32
有価証券報告書-第96期(2015/04/01-2016/03/31)
Japanese 803.8 KB
2016-02-10 01:35
四半期報告書-第96期第3四半期(2015/10/01-2015/12/31)
Japanese 177.8 KB
2015-11-12 01:21
四半期報告書-第96期第2四半期(2015/07/01-2015/09/30)
Japanese 204.6 KB

Automate Your Workflow. Get a real-time feed of all KAKEN PHARMACEUTIAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAKEN PHARMACEUTIAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAKEN PHARMACEUTIAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.